Health & Food
FDA approves new 4-in-1 pill to fight HIV
WASHINGTON (KABC) -- The Food and Drug Administration has approved a new pill to fight HIV. It's a once-a-day pill called Stribild that combines four medicines.
Gilead Sciences, who developed the drug, says 88 to 90 percent of patients taking it had an undetectable level of HIV in their blood after 48 weeks.
The pill contains two previously approved antiviral drugs, emtricitabine and tenofovir disoproxil fumarate, currently sold as the combination pill Truvada. Those drugs are combined with two new drugs: elvitegravir and cobicistat. Elvitegravir interferes with one of the enzymes that HIV needs to multiply. Cobicistat helps prolong the effect of elvitegravir.
Stribild will carry a warning about potentially dangerous side effects, including severe liver problems and the buildup of lactic acid.
An estimated 1.2 million Americans have HIV, which develops into AIDS unless treated with antiviral drugs. AIDS causes the body's immune system to break down, leading to infections which are eventually fatal.
The Associated Press contributed to this report.
fda, health, health care, health & food
- Anaheim Hills school bus crash: 9 injured 1 min ago
- Big-rig crash shuts down 210 Fwy, Gold Line 1 min ago
- Protesters commemorate Armenian Genocide
- Metro votes to keep ExpressLanes program
- Willowbrook gunman kills teen at apartment
- LAPD Mid-City station shooter dies of injuries
- Oxnard teacher arrested for child annoyance
- NorCal bus crash: Mother of student sues FedEx
- Afghan hospital guard kills 3 American doctors
- Ferry death toll at 175; families outraged
- abcnews: 'SOS' message saves marooned snorkelers
- Obama: Asia-Pacific trade deal not in danger
- Olivia Wilde, Jason Sudeikis welcome baby boy
- OTRC: Beyonce on '100 Most Influential People' cover
- Pet of the Week: Mini Pinscher named Tabasco
43 min ago